MoneyWorks4Me

Ind-Swift Laboratories informs about disclosure

03 Apr 2024 Evaluate
Ind-Swift Laboratories has attached disclosure received by the Company from Essix Biosciences, as per Regulation 10(6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, in respect of acquisition of 94,99,720 (Ninety-Four Lakhs Ninety-Nine Thousand Seven Hundred and Twenty) equity shares of Ind-Swift Laboratories by way of inter-se transfer among the promoters.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..